National Cancer Institute Perspectives
Copyright policy )National Cancer Institute Perspectives
The National Cancer Institute (NCI) Perspectives this year presented information on the systemic targeted radionuclide therapy (STaRT) research projects: (1) being investigated at the NCI's Intramural Center for Cancer Research; (2) funded by NCI's Radiation Research Program and other extramural programs; and (3) the appropriate National Institutes of Health/NCI funding mechanisms applicable to researchers for obtaining funds for STaRT projects.
- National Institutes of Health United States
- National Institute of Health Pakistan
- National Cancer Institute United States
- National Institutes of Health Malaysia
- National Cancer Institute Ukraine
Biomedical Research, Immunotoxins, Antibodies, Monoclonal, Radioimmunotherapy, Trastuzumab, Antibodies, Monoclonal, Humanized, Recombinant Proteins, United States, National Institutes of Health (U.S.), Neoplasms, Research Support as Topic, Humans
Biomedical Research, Immunotoxins, Antibodies, Monoclonal, Radioimmunotherapy, Trastuzumab, Antibodies, Monoclonal, Humanized, Recombinant Proteins, United States, National Institutes of Health (U.S.), Neoplasms, Research Support as Topic, Humans
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).1 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!